SEC Form SC 13G/A filed

$TLRY
Medicinal Chemicals and Botanical Products
Health Care
Get the next $TLRY alert in real time by email
SC 13G/A 1 ea135748-sc13ga3etf_tilray.htm AMENDMENT NO. 3 TO SCHEDULE 13G

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 3)*

 

Tilray Inc.
(Name of Issuer)
 
Common Stock, $0.001 Par Value Per Share
(Title of Class of Securities)
 
88688T100
(CUSIP Number)
 
February 12, 2021
(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☒ Rule 13d-1(b)

 

☐ Rule 13d-1(c)

 

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

SCHEDULE 13G

 

CUSIP No. 88688T100

 

1 Names of Reporting Persons
  ETF Managers Group LLC
2 Check the appropriate box if a member of a Group (see instructions)
  (a)  ☐
(b)  ☒ See Item of attached schedule
3 Sec Use Only
4 Citizenship or Place of Organization
  Delaware

Number of
Shares
Beneficially
Owned by Each
Reporting Person
With:

5 Sole Voting Power
  5,446,196
6 Shared Voting Power
   
7 Sole Dispositive Power
  5,446,196
8 Shared Dispositive Power
   

9 Aggregate Amount Beneficially Owned by Each Reporting Person
  5,446,196
10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
 
11 Percent of class represented by amount in row (9)
  4.08%
12 Type of Reporting Person (See Instructions)
  IA

 

Page 2 of 5

 

 

Item 1.

 

(a)Name of Issuer: Tilray Inc.

 

(b)Address of Issuer’s Principal Executive Offices: 1100 Maughan Road Nanaimo, BC V9X 1J2 Canada

 

Item 2.

 

(a)Name of Person Filing: ETF Managers Group LLC

 

(b)Address of Principal Business Office or, if None, Residence:

 

ETF Managers Group LLC - 30 Maple Street, Suite 2, Summit, New Jersey 07091

 

(c)Citizenship: ETF Managers Group LLC – Delaware

 

(d)Title and Class of Securities: Common Stock

 

(e)CUSIP No.: 88688T100

 

Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under Section 15 of the Act;
       
  (b) Bank as defined in Section 3(a)(6) of the Act;
       
  (c) Insurance company as defined in Section 3(a)(19) of the Act;
       
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940;
       
  (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       
  (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       
  (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

 

Page 3 of 5

 

 

Item 4.Ownership

 

(a)Amount Beneficially Owned: 5,446,196

 

(b)Percent of Class: 4.08%

 

(c)Number of shares as to which such person(s) has:

 

(i)Sole power to vote or to direct the vote: 5,446,196

 

(ii)Shared power to vote or to direct the vote:

 

(iii)Sole power to dispose or to direct the disposition of: 5,446,196

 

(iv)Shared power to dispose or to direct the disposition of:

 

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

 

Item 6.Ownership of more than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7.Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

 

Not Applicable

 

Item 8.Identification and classification of members of the group.

 

Not Applicable.

 

Item 9.Notice of Dissolution of Group.

 

Not Applicable

 

Item 10.Certifications.

 

By signing below, we certify that, to the best of our knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 4 of 5

 

 

SIGNATURE

 

After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.

 

Dated:  February 16, 2021

 

/s/ Reshma A. Tanczos  

Name/Title: Reshma A. Tanczos,
Chief Compliance Officer,
ETF Managers Group LLC

 

 

Page 5 of 5

 

Get the next $TLRY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TLRY

DatePrice TargetRatingAnalyst
4/5/2024$2.25 → $2.75Neutral
Alliance Global Partners
11/2/2022$3.90Mkt Perform
Bernstein
7/29/2022$3.00Hold → Sell
The Benchmark Company
3/4/2022$9.00Hold → Buy
Canaccord Genuity
1/11/2022$7.40 → $6.90Neutral
Cantor Fitzgerald
1/7/2022$11.80 → $7.40Neutral
Cantor Fitzgerald
11/18/2021$10.00Underweight
Barclays
11/1/2021$18.00 → $11.80Overweight → Neutral
Cantor Fitzgerald
More analyst ratings

$TLRY
Press Releases

Fastest customizable press release news feed in the world

See more
  • Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

    NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Tilray Successfully Prevails with Dismissal of HEXO Shareholder Lawsuit

    NEW YORK and LEAMINGTON, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Tilray Brands Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), and its subsidiary HEXO Corporation ("HEXO"), announced the successful dismissal of the Clement Italume vs. Robinhood Markets Inc., Robinhood Financial LLC, HEXO and Tilray lawsuit as against them. Specifically, the Massachusetts Superior Court, Suffolk County, granted Tilray's and HEXO's summary judgment motion in full, dismissing Clement Italume's ("Plaintiff") claims. The Court previously ruled that the Plaintiff's claims against the Robinhood defendants are subject to arbitration. The Plaintiff sought damages totalling approximately $8 million, alleging that

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail

    Tilray Expands Their Health-Focused Food and Beverage Portfolio with the Reintroduction of a Beloved Energy Drink, Hi*Ball Energy NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Tilray Wellness, the better-for-you food and beverage division of Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), is expanding their collaboration with Whole Foods Market this spring by re-introducing a beloved energy brand—Hi*Ball Energy—into US retail distribution. Made with zero calories and zero sugar, Hi*Ball supports sustained energy without compromises. Hi*Ball Energy Makes a Comeback Once a staple for Whole Foods Market and Natural Channel consumers, Hi*Ball Energy was a pioneer in the

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

$TLRY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$TLRY
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$TLRY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$TLRY
SEC Filings

See more

$TLRY
Leadership Updates

Live Leadership Updates

See more
  • Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA

    ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men's Health During Movember

    PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Breckenridge Brewery Opens New Location in Fort Collins, Colorado

    FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

$TLRY
Financials

Live finance-specific insights

See more
  • Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

    NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Tilray Brands Reports Q2 2025 Financial Results

    Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods co

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
  • Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

    NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025. This change reflects the observance of the National Day of Mourning in honor of former President Jimmy Carter. Live Conference Call and Audio Webcast Tilray will host a live conference call, w

    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

$TLRY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more